![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 21, 2020 9:12:11 AM
7:34 am ET April 21, 2020 (Dow Jones)
By Colin Kellaher
Laboratory Corp. of America on Tuesday said it received an emergency-use authorization from the U.S. Food and Drug Administration for its at-home test kit for Covid-19.
The Burlington, N.C., medical-testing giant said the authorization permits nasal-swab specimens to be collected at home using the Pixel by LabCorp collection kit if recommended by a healthcare provider after completing a Covid-19 questionnaire.
LabCorp said the self-collection kits will initially be available to healthcare workers and first responders who may have been exposed to Covid-19 or may be symptomatic, adding it plans to make the kits available to consumers in the coming weeks.
The company said enabling individuals to self-administer sample collection will help prevent the risk of transmitting the virus to others and reduce demand for personal protective equipment."
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM